An international Phase IV field study - psychometric properties of the updated module on assessing quality of life of patients with breast cancer EORTC QLQ-BR42

The revised EORTC QLQ-BR42 questionnaire incorporates the EORTC-QLQ-BR23 original items, combined with 19 new items that address the new therapies developed over the past 20 years. This comprehensive module is a valid instrument to assess the HRQoL of BC patients and can be used in place of the BR23 in future trials.

Authors

Institutions

Publication Details

Journal
The Breast
Published
2025-01-27
DOI
https://doi.org/10.1016/j.breast.2025.103890
Citations
9
Primary Topic
Cancer survivorship and care
Type
article
Field-Weighted Citation Impact
9.41

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

An international Phase IV field study - psychometric properties of the updated module on assessing quality of life of patients with breast cancer EORTC QLQ-BR42

Étienne Brain, Monica Pinto, David Cameron, C.-S. Huang et al.
9 citations
The Breast
Cancer survivorship and care
9.41
article

An international Phase IV field study - psychometric properties of the updated module on assessing quality of life of patients with breast cancer EORTC QLQ-BR42

Étienne Brain, Monica Pinto, David Cameron, C.-S. Huang, Juan Ignacio Arrarás, Katarzyna Pogoda, Thierry Conroy, Samantha Serpentini, Vesna Bjelic‐Radisic, Parisa Sinai, Andrew Bottomley, Fátima Cardoso, Omar Shamieh, Razvan Galalae, Ofir Morag, Roberto Vieira, François Duhoux, Galina Velikova, Manjunath Nookala, Brigitte Bliem, Sue M. Hartup, Elfriede Greimel, Yuichiro Kikawa, Eveline M. A. Bleiker, Akira Shimomura, N. H. M. Hoefnagels, G. Astrup, Wei‐Chu Chie, Neil K. Aaronson, Mirjam A. G. Sprangers, Karin Kuljanić, Joachim Weis, Elisabeth C. Sturm-Inwald, Yarad Belete Belay, Mikyas Amare Getu, Nora Nevries, Krzysztof Tomaszweski
article en
9 citations

Abstract

The revised EORTC QLQ-BR42 questionnaire incorporates the EORTC-QLQ-BR23 original items, combined with 19 new items that address the new therapies developed over the past 20 years. This comprehensive module is a valid instrument to assess the HRQoL of BC patients and can be used in place of the BR23 in future trials.

The BreastVol. 80
Champalimaud Foundation (PT), Oslo University Hospital (NO), University of Leeds (GB), University of Rijeka (HR), National Taiwan University (TW), Medical University of Graz (AT), Leeds Teaching Hospitals NHS Trust (GB), University Medical Center Freiburg (DE), Southmead Hospital (GB), St James's University Hospital (GB), Edinburgh Cancer Research (GB), University Hospital Regensburg (DE), University of Bristol (GB), Hospital de Câncer de Barretos (BR), National Center for Global Health and Medicine (JP), European Organisation for Research and Treatment of Cancer (BE), Tumor- und Brustzentrum ZeTuP Silberturm (CH), Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" (IT), Andrzej Frycz Modrzewski Krakow University (PL), The Maria Sklodowska-Curie National Research Institute of Oncology (PL), Amsterdam University Medical Centers (NL), MedAustron (AT), Tikur Anbessa Hospital (ET), Institut Curie (FR), University of Amsterdam (NL)
European Organisation for Research and Treatment of Cancer
Openalex Percentile: Top 2%
Cancer survivorship and care
9.41
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.